PATENT CLAIM ANALYSIS

Application Number: 16118001
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "356000"]

Abstract:
Disclosed herein are methods of treating disease with a combination of a RXR agonist and a thyroid hormone.

Claim (Index 1):
A method of treating a nervous system disorder, the method comprising administering to an individual in need thereof a therapeutically effective amount of a RXR agonist and a thyroid hormone, wherein administration of the combination of the RXR agonist and the thyroid hormone treats the nervous system disorder in the individual, wherein the RXR agonist is 3,7-dimethyl-6(S),7(S)-methano,7-[1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphth-7-yl]2(E),4(E) heptadienoic acid, and has the structure of formula Ill: and wherein the combination of RXR agonist and thyroid hormone causes a greater improvement in the nervous system disorder than the RXR agonist or thyroid hormone alone; the method further comprising administration of a neurotrophic factor, or neurotrophic factor mimetic.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 96.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15339762', '15812821', '15339752', '14507730', '15988965']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8624920431072037
- 35 USC 102 Novelty (BERT): 0.6982050168898145
- Combined Prediction Score: 0.8460633404854648
- Mean Citation Score: 611.4666759999999
- Max Citation Score: 747.0627
- Similarity Product: 727.283849599582

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test